InvestorsHub Logo
Followers 49
Posts 4143
Boards Moderated 1
Alias Born 05/20/2014

Re: None

Thursday, 04/25/2019 9:48:23 PM

Thursday, April 25, 2019 9:48:23 PM

Post# of 37521
Karyemaître Aliffe, MD
1st
FORWARD-LOOKING, ENTREPRENEURIAL PHYSICIAN-SCIENTIST. Visionary, Multilingual Biomedical Executive, Translating Medicinal Science Breakthroughs into Novel Therapeutic Agents and Cannabinoid-centered Health Products.
Stanford University School of Medicine
Greater Seattle Area500


Medical•Science Advisory Board~ Medicinal Cannabinoids Research & Business Development
***** Health
Jun 2017 - Present1 yr 11 mos
USA & MEXICO
Early-stage, Biotech-driven, Translational Medicine Company~
Translating Marijuana Folk Medicine into Clinical-Quality Cannabinoid Medicines
Applying molecular pharmacognosy to yield safe and effective, IP-rich, cannabis-centered products in support of optimal well-being and sustainable longevity.
• Consumer and B2B markets North America (USA, México and Canada), South America and Australia.
• Endocannabinoid Synergy Product Development Pipeline~ Clinical Trials and Consumer Testing.
• Science-driven Branding & Marketing, Regulatory and Intellectual Property Strategies.
• International Academic and Basic Science Research Liaison.
• Ethics-centered Regulatory Lobbying and New Business Development.
• Health Practitioner and Community Education Programs & Resources.
• Mobile Endocannabinoid System Personal Health Consultation Services